Supports early-career researchers conducting clinical research to advance understanding and treatment of ALS, ALS-FTD, PLS, PMA, and HSP.
Funder: American Academy of Neurology
Due Dates (Anticipated): March 2028
Funding Amounts: Award amount and duration not specified; typically supports early-career clinical research in neurodegenerative diseases.
Summary: Supports young investigators conducting clinical research on ALS, ALS-FTD, PLS, PMA, and HSP to advance understanding and treatment.
Key Information: This award is not offered for the 2027 cycle; next anticipated application round is March 2028.
This award supports early-career or young investigators undertaking clinical research in the field of neurodegenerative diseases, with a focus on amyotrophic lateral sclerosis (ALS), ALS-frontotemporal dementia (ALS-FTD), primary lateral sclerosis (PLS), progressive muscular atrophy (PMA), and hereditary spastic paraplegia (HSP). The objective is to encourage innovative research that advances both the understanding and treatment of these conditions.